VivoSim Labs, Inc. Shareholders' Equity
VivoSim Labs, Inc. (VIVS) had Shareholders' Equity of -$2.35 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$2.35M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.10M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $4.44M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.07M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$2.35M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$1.10M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $4.44M 10-Q · filed 2026-02-11 |
| 2025-09-30 | $7.07M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.54M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $10.49M 10-K · filed 2026-07-14 |
| 2024-12-31 | $364.00K 10-K · filed 2025-06-05 |
| 2024-09-30 | $3.68M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.66M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $3.60M 10-K · filed 2025-06-05 |
| 2023-12-31 | $6.18M 10-Q · filed 2024-02-08 |
| 2023-09-30 | $8.46M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.78M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $15.33M 10-K · filed 2024-05-31 |
| 2022-12-31 | $22.29M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $25.01M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $27.65M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $30.21M 10-K · filed 2023-07-14 |
| 2021-12-31 | $31.29M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $34.21M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $37.33M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $39.20M 10-K · filed 2022-06-10 |
| 2020-12-31 | $20.75M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $19.99M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $24.79M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $26.63M 10-K · filed 2021-06-15 |
| 2019-12-31 | $28.95M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $31.07M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $36.14M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $36.30M 10-K · filed 2020-05-28 |
| 2018-12-31 | $35.67M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $38.87M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $41.36M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $44.59M 10-K · filed 2019-06-03 |
| 2017-12-31 | $48.60M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $52.06M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $57.27M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $62.36M 10-K · filed 2018-05-31 |
| 2016-12-31 | $70.90M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $52.49M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $54.84M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $62.18M 10-K · filed 2017-06-07 |
| 2015-12-31 | $69.04M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $76.15M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $85.32M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $48.70M 10-K · filed 2016-06-09 |
| 2014-12-31 | $48.31M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $53.43M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $43.82M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $48.28M 10-K · filed 2015-06-09 |
| 2013-03-31 | $8.97M 10-K · filed 2014-06-10 |
| 2012-12-31 | -$5.30M 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |